Delivery Order SPE2DR25D2101-SPE2DR26F45PS
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 21, 2025, with a ceiling value of $1,955.59 for the supply of XEOMIN 100 Unit Vials. The contract is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award was made through competitive procedures with no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $33,524.40 for XEOMIN 100 unit vials under a firm fixed price contract with the Medical Supply Chain, a component of the Defense Logistics Agency. The award, issued on August 25, 2025, is scheduled for completion by September 16, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a competitive award with no set-aside designation and is issued as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XEOMIN 100 unit vials valued at $2,793.70 on October 29, 2025, with an ultimate completion date of November 20, 2025. This firm fixed price contract represents a non-competitive, non-set-aside award and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Xeomin 50 unit vials valued at $10,941.84. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with a completion date of September 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order falls under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes, valued at $42,642.60. This firm fixed-price delivery order, awarded on September 25, 2025, with an ultimate completion date of October 17, 2025, was competitively awarded without set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,587.40 for 100-unit vials of XEOMIN on June 9, 2025, with completion scheduled for July 1, 2025. This firm fixed-price, non-competitive delivery order was issued through the Defense Logistics Agency's Medical Supply Chain to support federal medical procurement needs. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion...
- The Defense Logistics Agency awarded a delivery order valued at $24,730.44 to AmerisourceBergen Drug Corp for the supply of XEOMIN 100 UT vials on a firm fixed price basis. This non-set-aside contract was awarded on November 10, 2025, with an ultimate completion date of November 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is fulfilling this order from its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $14,806.61 by the Defense Logistics Agency's Medical Supply Chain on July 31, 2025, for the supply of XEOMIN 100 UT vials. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 27, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is...
- The Defense Logistics Agency awarded a delivery order valued at $13,409.76 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit Vials, with a completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on August 13, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order falls under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $6,704.88 delivery order to AmerisourceBergen Drug Corp for XEOMIN 100 Unit Vials on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price delivery order represents a standalone purchase with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and headquarters. This delivery order is...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F45PSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,888.30 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 Unit Vials, with an ultimate completion date of December 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award is a child contract executed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and runs through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical supply vendor that serves military and veteran healthcare systems through its extensive portfolio of pharmaceutical products and medical supplies. The company maintains a significant presence in DLA Medical Supply Chain procurement, regularly fulfilling orders for brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for XEOMIN, a botulinum toxin product used for medical applications, represents one component of the company's ongoing support to federal healthcare customers including the Defense Health Agency and U.S. Coast Guard through the comprehensive DLA pharmaceutical prime vendor contract structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 11/10/25 |